DORNASE ALFA: WHAT EFFECTIVENESS OF MEDICATION DEPENDS ON?
The treatment with dornase alfa (Pulmozyme) plays one of the key roles in basic treatment of cystic fibrosis as in children as in adult patients. But effectiveness of this medication depends on different important constituents, starting from its proper administration, to precise execution of intake...
Saved in:
Main Author: | O.I. Simonova |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2009-07-01
|
Series: | Вопросы современной педиатрии |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/1157 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS
by: O.I. Simonova
Published: (2011-07-01) -
AN IMPORTANT COMPONENT OF BASIC THERAPY IN CYSTIC FIBROSIS (MUCOVYSCIDOSIS) IN CHILDREN: DORNASE ALFA
by: O.I. Simonova
Published: (2011-10-01) -
PECULIARITIES OF DORNASE ALFA AND KINESITHERAPY USE IN CHILDREN WITH CYSTIC FIBROSIS
by: O. I. Simonova
Published: (2013-07-01) -
DORNASE ALPHA: THREE CLINICAL EFFECTS
by: O.I. Simonova
Published: (2008-03-01) -
A MUCOLYTIC WITH ANTIINFLAMMATORY QUALITIES FOR CHILDREN SUFFERED FROM CYSTIC FIBROSIS: DORNASE ALFA
by: O. I. Simonova, et al.
Published: (2012-12-01)